Moleculin Biotech (MBRX) Operating Leases (2019 - 2026)
Moleculin Biotech (MBRX) posted Operating Leases of $147,000 for Q2 2026, down 49.7% from $292,000 a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Operating Leases came in at $222,000, down 38.0% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- In prior years, Moleculin Biotech's Operating Leases was $358,000 in FY2024 (-24.5%), $474,000 in FY2023 (+41.5%), $335,000 in FY2022 (+431.7%) and $63,000 in FY2021 (-60.4%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q1 2022.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q1 2023, with growth of 516.0%; the weakest was Q1 2022, with a decline of 60.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Moleculin Biotech | 3.24 Mn | 3.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 147,000.00 |
| Dec 31, 2025 | 222,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 292,000.00 |
| Mar 31, 2025 | 326,000.00 |
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 390,000.00 |
| Jun 30, 2024 | 420,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 474,000.00 |
| Sep 30, 2023 | 496,000.00 |
| Jun 30, 2023 | 291,000.00 |
| Mar 31, 2023 | 308,000.00 |
| Dec 31, 2022 | 335,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 388,000.00 |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 63,000.00 |
| Sep 30, 2021 | 75,000.00 |
| Jun 30, 2021 | 94,000.00 |
API Access
Moleculin Biotech Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();